RECENT NEWS

​Action on Pre-eclampsia (APEC) has welcomed the Scottish Government’s announcement of dedicated funding for pre-eclampsia testing in every Health Board – helping to protect thousands of pregnant mothers and babies in Scotland. This means that, for the first time, expectant mothers in Scotland will soon have access to placental growth factor (PlGF) testing, a simple blood test to help diagnose pre-eclampsia that has been available in England since 2016.

Cardiovascular disease (CVD) remains the most common cause of death across Europe but while CVD mortality rates are generally decreasing, the decline is much less in middle-income than in high-income countries.

The UK Health Security Agency (UKHSA) is reminding all higher education and university students – freshers and returning students – to make sure they are up to date with their free NHS childhood and adolescent vaccines against meningitis, measles and HPV ahead of starting the new academic year.

Ambulance crews spend significant time diverting resources to 999 callouts in prisons that are cancelled or not a serious enough medical emergency, says a new report from HSSIB.

Clinical follow-up using virtual voice technology helped identify complications after transcatheter aortic valve implantation (TAVI) with a high degree of patient satisfaction, according to research presented at ESC Congress 2024.

An inspiring webinar, taking place on 5th September 2024, aims to shine a spotlight on the remarkable achievements of female founders, CEOs, and CTOs spearheading innovation in the fast-paced world of HealthTech.

New research, presented at this year’s ESC Congress 2024 in London, shows that performing echocardiograms remotely using a 5G cellular network has similar accuracy to those performed in person by cardiologists.

Alpha Laboratories has announced that it has entered into a strategic partnership with Clinical Design Technologies, to market and support the 'world's first digital closed urine testing system'.

Childhood obesity can contribute to the development of common immune-mediated skin diseases (IMSDs), such as alopecia areata, atopic dermatitis, and psoriasis, new research finds.

The World Health Organization (WHO) has launched a global Strategic Preparedness and Response Plan to stop outbreaks of human-to-human transmission of mpox through coordinated global, regional, and national efforts.

Scientists at the University of Nottingham are scaling up the development of a new Zika virus DNA vaccine thanks to a collaboration with specialist company, Touchlight, who will provide new technology to produce large quantities of the DNA vaccine at speed.

Blood packs have been successfully flown by drone in a series of ‘beyond visual line of sight’ flights, for the first time in the UK.

One-third of participants with type 2 diabetes who complete the NHS England Type 2 Diabetes Path to Remission programme, involving the ‘soups and shakes’ diet, enter remission, new research shows.

New data from the UK Health Security Agency (UKHSA) highlights a concerning rise in antibiotic-resistant gonorrhoea infections in England.

CHEC, a provider of community healthcare, has completed the fit out of its new community ophthalmology hospital in Leeds.

The NHS has announced a new partnership with libraries across England to help more people access online health services and use the NHS App.

​NHS England and the Medical Schools Council have launched a new partnership that will give students the opportunity to apply directly to medical schools for certain Specialised Foundation Programmes in England.

A study published in Eurosurveillance has found that prior smallpox vaccination in childhood could protect against infections caused by monkeypox virus (MPXV) clade II in men.

A research team from the University of Waterloo, in Canada, has developed a new material that shares many of the same traits as bone tissue. Using it in 3D printers provides a new and innovative treatment option for patients undergoing major skeletal repair and reconstructive surgery.

NHS SBS has designed an Insourcing of Clinical Services framework agreement to help the NHS secure extra clinical capacity, enabling Trusts to retain capacity planning in-house and ensure patients can be seen within the Trust.